Intravitreal enzyme replacement preserves retinal structure and function in canine CLN2 neuronal ceroid lipofuscinosis-Reference-Cited by-同舟云学术

Intravitreal enzyme replacement preserves retinal structure and function in canine CLN2 neuronal ceroid lipofuscinosis

Published:2020-08 Issue: Volume:197 Page:108130
ISSN:0014-4835
Container-title:Experimental Eye Research
language:en
Short-container-title:Experimental Eye Research

Author:

Whiting Rebecca E.H.^ORCID,Pearce Jacqueline W.,Vansteenkiste Daniella P.,Bibi Katherine^ORCID,Lim Stefanie,Robinson Kick Grace^ORCID,Castaner Leilani J.,Sinclair John^ORCID,Chandra Sundeep,Nguyen Annalisa,O'Neill Charles A.,Katz Martin L.

Funder

BioMarin Pharmaceutical

BioMarin

U.S. National Institutes of Health

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference49 articles.

1. A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis;Awano;Mol. Genet. Metabol.,2006

2. Principles of pharmacology in the eye;Awwad;Br. J. Pharmacol.,2017

3. Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis;Ba;Drug Des. Dev. Ther.,2015

4. Bilateral intraocular inflammation after intravitreal bevacizumab in Behcet's disease;Bae;Eye,2010

5. Intraocular inflammation following intravitreal injection of bevacizumab;Bakri;Graefes Arch. Clin. Exp. Ophthalmol.,2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerliponase alfa and neuronal ceroid lipofuscinosis type 2: long-term outcomes and lessons for future research;The Lancet Neurology;2024-01

2. Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study;The Lancet Neurology;2024-01

3. Intravitreal enzyme replacement for inherited retinal diseases;Current Opinion in Ophthalmology;2023-12-26

4. First in man study of intravitreal tripeptidyl peptidase 1 for CLN2 retinopathy;Eye;2023-12-04

5. Intravitreal gene therapy preserves retinal function in a canine model of CLN2 neuronal ceroid lipofuscinosis;Experimental Eye Research;2023-01